Citation Impact
Citing Papers
A Comparison of Rate Control and Rhythm Control in Patients with Atrial Fibrillation
2002 Standout
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
2014 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
2009 Standout
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
2007 StandoutNobel
Bariatric surgery and cardiovascular outcomes: a systematic review
2012
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial
2008
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Catheter Ablation for Atrial Fibrillation in Patients With Left Ventricular Systolic Dysfunction. A Systematic Review and Meta-Analysis
2011
Indications for the use of diagnostic implantable and external ECG loop recorders
2009
Impact of the CHA2DS2-VASc Score on Anticoagulation Recommendations for Atrial Fibrillation
2012
Short sleep duration and cardiometabolic risk: from pathophysiology to clinical evidence
2018
Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial
2016
Universal Definition of Myocardial Infarction
2007 Standout
Association Between C-Reactive Protein and Recurrence of Atrial Fibrillation After Successful Electrical Cardioversion
2007
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
2010 Standout
Health Literacy and Cardiovascular Disease: Fundamental Relevance to Primary and Secondary Prevention: A Scientific Statement From the American Heart Association
2018
Underuse of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review
2010
Early Identification of Refractory Epilepsy
2000 Standout
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
2009 Standout
Selective spider toxins reveal a role for the Nav1.1 channel in mechanical pain
2016 StandoutNatureNobel
Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? A systematic review and meta-analysis
2014
Experiences of Driving and Driving Restrictions in Recipients With an Implantable Cardioverter Defibrillator-The Patient Perspective
2010
Low-Back Pain in Morbidly Obese Patients and the Effect of Weight Loss Following Surgery
2003
Reducing Unnecessary Right Ventricular Pacing with the Managed Ventricular Pacing Mode in Patients with Sinus Node Disease and AV Block
2006
A New Paradigm for Physiologic Ventricular Pacing
2006
Differential Use of Warfarin for Secondary Stroke Prevention in Patients With Various Types of Atrial Fibrillation
2008
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
2017 Standout
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
2009 Standout
Patients with Refractory Seizures
1999
Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation
2011
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
2012
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation
2002
Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a ‘real world’ atrial fibrillation population: A modelling analysis based on a nationwide cohort study
2011
Management of atrial fibrillation in patients with heart failure
2007
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Efficacy and safety of direct oral anticoagulants in patients undergoing cardioversion for atrial fibrillation: A systematic review and meta-analysis of the literature
2015
Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study
2012
Cardioversion and Risk of Adverse Events with Dabigatran versus Warfarin—A Nationwide Cohort Study
2015
Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study)
2013
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
2013 Standout
Four-Year Efficacy of Cardiac Resynchronization Therapy on Exercise Tolerance and Disease Progression
2006
Impact of bariatric surgery on cardiac structure, function and clinical manifestations in morbid obesity
2004
Biventricular Versus Conventional Right Ventricular Stimulation for Patients With Standard Pacing Indication and Left Ventricular Dysfunction
2006
Effectiveness of Amiodarone for Conversion of Atrial Fibrillation to Sinus Rhythm
2003
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation
2010
Fabrication and preliminary study of a biomimetic tri-layer tubular graft based on fibers and fiber yarns for vascular tissue engineering
2017
Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort study
2012
Mechanisms of Apnea
2008
Use of the Electrocardiogram in Acute Myocardial Infarction
2003
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 3-Year Outcomes
2014 Standout
Atrial fibrillation
2011
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Physiology and Pathophysiology of Sodium Channel Inactivation
2016
Left ventricular non-compaction revisited: a distinct phenotype with genetic heterogeneity?
2011
Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction
2013
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
2009 Standout
Circadian pattern of life-threatening ventricular arrhythmia in patients with sleep-disordered breathing and implantable cardioverter-defibrillators
2010
Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural Pathways
2017 StandoutNobel
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
2007
Subclinical Atrial Fibrillation and the Risk of Stroke
2012
Are Atrial Fibrillation Patients Receiving Warfarin in Accordance with Stroke Risk?
2010
Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: review of evidence and clinical relevance
2009
Neuroplasticity and dysfunction after gastrointestinal inflammation
2014
Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention
2011
Progression From Paroxysmal to Persistent Atrial Fibrillation
2010
Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention
2011
Functional abnormalities in patients with permanent right ventricular pacing
2002
Third Universal Definition of Myocardial Infarction
2012 Standout
A randomized placebo-controlled trial of pre-treatment and short- or long-term maintenance therapy with amiodarone supporting DC cardioversion for persistent atrial fibrillation
2004
Ethical and legal perspective of implantable cardioverter defibrillator deactivation or implantable cardioverter defibrillator generator replacement in the elderly
2012
Analysis of Interaction of Acute Atrial Overdrive Pacing with Sleep-Related Breathing Disorder
2006
Antiarrhythmic Drugs for Maintaining Sinus Rhythm After Cardioversion of Atrial Fibrillation
2006
Carvedilol's antiarrhythmic properties: Therapeutic implications in patients with left ventricular dysfunction
2005
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Sex and Gender Differences in Clinical Medicine
2012
Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation*
2009
Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial
2011
Melanocyte-like cells in the heart and pulmonary veins contribute to atrial arrhythmia triggers
2009
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Antithrombotic Therapy in Atrial Fibrillation
2008
Management of patients receiving implantable cardiac defibrillator shocks: Recommendations for acute and long-term patient management
2010
Systematic review of pregnancy in women with inherited cardiomyopathies
2011
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Aortic Atherosclerotic Disease and Stroke
2006
Socioeconomic Status and Cardiovascular Outcomes
2018
Educational and Psychological Interventions to Improve Outcomes for Recipients of Implantable Cardioverter Defibrillators and Their Families
2012
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Electrospinning and Electrospun Nanofibers: Methods, Materials, and Applications
2019 Standout
Safety and Efficacy of Novel Oral Anticoagulants Versus Warfarin in Medicare Beneficiaries With Atrial Fibrillation and Valvular Heart Disease
2018
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
Sleep Apnea and Cardiovascular Disease
2008
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Machine Learning in Medicine
2015 Standout
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2019 Standout
Cardioversion of Atrial Fibrillation in ENGAGE AF‐TIMI 48
2016
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Pharmacological and surgical treatment of obesity.
2004
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial
2018
Sleep Apnea and Cardiovascular Disease
2008
Efficacy of Amiodarone for the Termination of Chronic Atrial Fibrillation and Maintenance of Normal Sinus Rhythm: A Prospective, Multicenter, Randomized, Controlled, Double Blind Trial
2001
American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death
2008
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Challenges of Establishing New Antithrombotic Therapies in Atrial Fibrillation
2007
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
2019
Distribution and Risk Profile of Paroxysmal, Persistent, and Permanent Atrial Fibrillation in Routine Clinical Practice
2012
Treatment of Atrial Fibrillation With Antiarrhythmic Drugs or Radiofrequency Ablation
2009
Worldwide Epidemiology of Atrial Fibrillation
2013 Standout
Long-Term Results of Catheter Ablation in Paroxysmal Atrial Fibrillation
2010
Sex, age, and time to cardioversion. Risk factors for cardioversion of acute atrial fibrillation from the FinCV study
2016
Pathological Ventricular Remodeling
2013
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Complementary roles of gasotransmitters CO and H2S in sleep apnea
2017 StandoutNobel
2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2012
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Pharmacology of the Na v 1.1 domain IV voltage sensor reveals coupling between inactivation gating processes
2017 StandoutNobel
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary
2006
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
2015
Meta-Analysis: Surgical Treatment of Obesity
2005 Standout
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2006
Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Lesions
2016
Catheter Ablation for Atrial Fibrillation with Heart Failure
2018
2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2012
Prevention of stroke in patients with atrial fibrillation: current strategies and future directions
2008
Pulmonary Vein Isolation for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation
2009
High Prevalence of Sleep Apnea Syndrome in Patients With Long-Term Pacing
2007
Obesity is associated with incident atrial fibrillation independent of gender: A meta‐analysis
2018
2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2012
Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS2 Score: A Subgroup Analysis of the RE-LY Trial
2011
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Works of Panos Vardas being referenced
Effects of the Long-Term Administration of Nebivolol on the Clinical Symptoms, Exercise Capacity, and Left Ventricular Function of Patients with Diastolic Dysfunction: Results of the ELANDD Study
2011
HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy
2010
Comparative assessment of right, left, and biventricular pacing in patients with permanent atrial fibrillation
2004
HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs): Description of Techniques, Indications, Personnel, Frequency and Ethical Considerations: Developed in partnership with the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA); and in collaboration with the American College of Cardiology (ACC), the American Heart Association (AHA), the European Society of Cardiology (ESC), the Heart Failure Association of ESC (HFA), and the Heart Failure Society of America (HFSA). Endorsed by the Heart Rhythm Society, the European Heart Rhythm Association (a registered branch of the ESC), the American College of Cardiology, the American Heart Association
2008
Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on Atrial Fibrillation
2008
Long-term Maintenance of Normal Sinus Rhythm in Patients With Current Symptomatic Atrial Fibrillation
2004
ESC-EURObservational Research Programme: the Atrial Fibrillation Ablation Pilot Study, conducted by the European Heart Rhythm Association
2012
Absence of atherosclerotic lesions in the thoracic aorta indicates absence of significant coronary artery disease
1996
Tools and strategies for the reduction of inappropriate implantable cardioverter defibrillator shocks
2008
Pharmacological Cardioversion of Recent Onset Atrial Fibrillation with Intravenous Amiodarone in Patients Receiving Long-Term Amiodarone Therapy: Is It Reasonable?
2003
Autonomic imbalance during the day in patients with inflammatory bowel disease in remission. Evidence from spectral analysis of heart rate variability over 24 hours
2002
Atrial Fibrillation and Heart Failure in Cardiology Practice: Reciprocal Impact and Combined Management From the Perspective of Atrial Fibrillation
2009
HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs): Description of Techniques, Indications, Personnel, Frequency and Ethical Considerations
2008
Serum Markers of Collagen Turnover Predict Future Shocks in Implantable Cardioverter-Defibrillator Recipients With Dilated Cardiomyopathy on Optimal Treatment
2010
Electrocardiographic Appearance of Old Myocardial Infarction in Paced Patients
2002
Comparative effects of carvedilol and amiodarone on conversion and recurrence rates of persistent atrial fibrillation
2004
Efficacy of amiodarone for the termination of persistent atrial fibrillation
1999
Effects of Amiodarone and Diltiazem on Persistent Atrial Fibrillation Conversion and Recurrence Rates: A Randomized Controlled Study
2003
Left ventricular mechanics during right ventricular apical or left ventricular-based pacing in patients with chronic atrial fibrillation after atrioventricular junction ablation
2004
Endothelial Cell Function During Atrial Fibrillation and After Restoration of Sinus Rhythm
2007
Cardiac pacing in sleep apnoea: diagnostic and therapeutic implications
2006
Assessment of autonomic function at rest and during tilt testing in patients with vasovagal syncope
1997
Inherited Brugada and Long QT-3 Syndrome Mutations of a Single Residue of the Cardiac Sodium Channel Confer Distinct Channel and Clinical Phenotypes
2001
Conversion of Atrial Fibrillation to Sinus Rhythm Using Acute Intravenous Procainamide Infusion
1998
Reproducibility of Electrocardiographic Findings in Patients With Suspected Reflex Neurally-Mediated Syncope
2008
Gender-Related Differences in Presentation, Treatment, and Outcome of Patients With Atrial Fibrillation in Europe
2007
Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options
2011
Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation
2006
Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope
2006
ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs)
2012
Amiodarone as a First-Choice Drug for Restoring Sinus Rhythm in Patients With Atrial Fibrillation
2000
Acute comparative effect of right and left ventricular pacing in patients with permanent atrial fibrillation
2004
Myocardial perfusion in patients with permanent ventricular pacing and normal coronary arteries
2001
Autonomic Nervous System Activity Before and During Episodes of Myocardial Ischemia in Patients with Stable Coronary Artery Disease During Daily Life
2000
Left Ventricular Function and Cardiopulmonary Performance Following Surgical Treatment of Morbid Obesity
2001
Atrial Overdrive Pacing for the Obstructive Sleep Apnea–Hypopnea Syndrome
2005
A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry
2013
Usefulness of Echo-Guided Cardiac Resynchronization Pacing in Patients Undergoing “Ablate and Pace” Therapy for Permanent Atrial Fibrillation and Effects of Heart Rate Regularization and Left Ventricular Resynchronization††A list of participating institutions and investigators appears in the Appendix.
2008
Sotalol versus propafenone for long-term maintenance of normal sinus rhythm in patients with recurrent symptomatic atrial fibrillation
2004
An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality
2010
Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation
2014
Sustainable Development Goals and the Future of Cardiovascular Health: A Statement From the Global Cardiovascular Disease Taskforce
2014
Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators
2009
Moving From Political Declaration to Action on Reducing the Global Burden of Cardiovascular Diseases
2013
Consensus Statement: Consensus Statement of the European Heart Rhythm Association: Updated Recommendations for Driving by Patients with Implantable Cardioverter Defibrillators
2010
P4-46
2006
Conceptus Radiation Dose and Risk From Cardiac Catheter Ablation Procedures
2001